Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors

被引：0
|
作者：
Thomas E. Stinchcombe
Mark A. Socinski
Christine M. Walko
Bert H. O’Neil
Frances A. Collichio
Anastasia Ivanova
Hua Mu
Michael J. Hawkins
Richard M. Goldberg
Celeste Lindley
E. Claire Dees
机构：
[1] University of North Carolina,Department of Hematology/Oncology, Developmental Therapeutics Group Lineberger Comprehensive Cancer Center
[2] University of North Carolina,School of Pharmacy
[3] Lineberger Comprehensive Cancer Center,Department of Biostatics
[4] Abraxis BioScience,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Dose-limiting toxicity; Maximum tolerated dose; Melanoma; Non-small-cell lung cancer; Small-cell lung cancer; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：759 / 766
页数：7
相关论文
共 50 条
  • [41] Phase I trial of carboplatin and paclitaxel with escalating doses of oral topotecan in patients with solid tumors
    Hanna, N
    Sweeney, C
    Fife, K
    Dropcho, S
    Seitz, DE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 200 - 202
  • [42] A Phase II Trial of Nab-Paclitaxel (ABI-007) and Carboplatin in Patients With Unresectable Stage IV Melanoma A North Central Cancer Treatment Group Study, N057E
    Kottschade, Lisa A.
    Suman, Vera J.
    Amatruda, Thomas, III
    McWilliams, Robert R.
    Mattar, Bassam I.
    Nikcevich, Daniel A.
    Behrens, Robert
    Fitch, Tom R.
    Jaslowski, Anthony J.
    Markovic, Svetomir N.
    CANCER, 2011, 117 (08) : 1704 - 1710
  • [43] Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel (vol 12, pg 1317, 2006)
    Desai, N
    Trieu, V
    Yao, Z
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3869 - 3869
  • [44] Pemetrexed in combination with paclitaxel: A phase I clinical and pharmacokinetic trial in patients with solid tumors.
    Graefe, T.
    Bolling, C.
    Lubbing, C.
    Latz, J.
    Blatter, J.
    Hanauske, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 91S - 91S
  • [45] Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
    Roy, V.
    LaPlant, B. R.
    Gross, G. G.
    Bane, C. L.
    Palmieri, F. M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 449 - 453
  • [46] A Phase I study of CC-486 (oral azacitidine) to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of azacitidine administered alone and in combination with carboplatin or ABI-007 (NAB-paclitaxel) in subjects with solid tumors.
    Laille, Eric
    Nguyen, Aaron N.
    Chen, Gengxi
    Rasco, Drew
    LoRusso, Patricia
    Von Hoff', Daniel D.
    Bendell, Johanna
    Munster, Pamela
    Edenfield, William J.
    Ramanathan, Ramesh
    Gonzalez, Michael B.
    Blackwood-Chirchir, Anne
    DiMartino, Jorge
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [47] A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer
    Nanda, R.
    Chennamaneni, P.
    Gibson, J.
    Koetter, K.
    Libao, B.
    Skor, M.
    Maranville, J.
    Hoffman, P.
    Obeid, E.
    DiRienzo, A.
    Fleming, G.
    Conzen, S.
    CANCER RESEARCH, 2013, 73
  • [48] Phase I Trial of Hepatic Arterial Infusion of Nanoparticle Albumin-Bound Paclitaxel: Toxicity, Pharmacokinetics, and Activity
    Fu, Siqing
    Naing, Aung
    Moulder, Stacy L.
    Culotta, Kirk S.
    Madoff, David C.
    Ng, Chaan S.
    Madden, Timothy L.
    Falchook, Gerald S.
    Hong, David S.
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (07) : 1300 - 1307
  • [49] A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer
    Nanda, Rita
    Stringer-Reasor, Erica M.
    Saha, Poornima
    Kocherginsky, Masha
    Gibson, Jean
    Libao, Bernadette
    Hoffman, Philip C.
    Obeid, Elias
    Merkel, Douglas E.
    Khramtsova, Galina
    Skor, Maxwell
    Krausz, Thomas
    Cohen, Ronald N.
    Ratain, Mark J.
    Fleming, Gini F.
    Conzen, Suzanne D.
    SPRINGERPLUS, 2016, 5
  • [50] Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
    Patnaik, A
    Warner, E
    Michael, M
    Egorin, MJ
    Moore, MJ
    Siu, LL
    Fracasso, PM
    Rivkin, S
    Kerr, I
    Litchman, M
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3677 - 3689
12345